-
21by Roger J Bedimo, Henning Drechsler, Mamta Jain, James Cutrell, Song Zhang, Xilong Li, Irfan Farukhi, Rosinda Castanon, Pablo Tebas, Naim M Maalouf“...+DRV/r did not achieve similar week 48 virologic efficacy compared with TDF/FTC+DRV/r, but was better...”
Published 2014-01-01
Get full text
Article -
22by Yusheng Jie, Chaoshuang Lin, Jing Yuan, Zhixin Zhao, Yujuan Guan, Yuanping Zhou, Xiaohui Zhou, Bihui Zhong, Yinong Ye, Lihua Zhang, Ling Tao, Jianping Li, Xiaohong Zhang, Yutian Chong“... of DSV twice daily for 8 weeks or 12 weeks. Sustained virological response at 12 weeks post-treatment...”
Published 2020-09-01
Get full text
Article -
23by Gregory D. Huhn, Joseph J. Eron, Pierre-Marie Girard, Chloe Orkin, Jean-Michel Molina, Edwin DeJesus, Romana Petrovic, Donghan Luo, Erika Van Landuyt, Erkki Lathouwers, Richard E. Nettles, Kimberley Brown, Eric Y. Wong“...) cumulative through week 48. Virologic response was VL < 50 copies/mL (FDA snapshot). Safety was assessed...”
Published 2019-08-01
Get full text
Article -
24by Eduardo Arathoon, Asad Bhorat, Rodica Silaghi, Herta Crauwels, Ludo Lavreys, Lotke Tambuyzer, Ben Van Baelen, Simon Vanveggel, Magda Opsomer“... was 353 ng/mL (N = 199). Week 48 virologic response rates (viral load < 50 copies/mL; Food and Drug...”
Published 2017-01-01
Get full text
Article -
25by Paula Munderi, Edwin Were, Anchalee Avihingsanon, Pascale A.M Mbida, Lerato Mohapi, Samba B. Moussa, Marjolein Jansen, Ceyhun Bicer, Perry Mohammed, Yvon van Delft“... = 213) or TDF/FTC/EFV (n = 211). At week 48, virologic suppression was maintained in 200/213 (93.9...”
Published 2019-07-01
Get full text
Article -
26by Yan Xu, Xu Wang, Zhenhua Liu, Changyu Zhou, Wenqian Qi, Jian Jiao, Fan Yu, Honghua Guo, Ping Zhao, Jiangbin Wang“... anti-viral therapy for 12 weeks. Sustained virological response (SVR) was defined as no change...”
Published 2017-08-01
Get full text
Article -
27by Jadir Rodrigues Fagundes Neto“... weeks, the virological response, evolution of CD4 T cells, the possible primary resistance to ENF...”
Published 2012
Get full text
Others -
28by Jadir Rodrigues Fagundes Neto“... weeks, the virological response, evolution of CD4 T cells, the possible primary resistance to ENF...”
Published 2012
Get full text
Others -
29Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)by Marina V. Mayevskaya, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda, V. T. Ivashkin“...® efficacy was carried out in 4 weeks (rapid virologic response, RVR) and 12 weeks of treatment (early...”
Published 2018-08-01
Get full text
Article